Find information on thousands of medical conditions and prescription drugs.

Hermansky-Pudlak syndrome

Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism), bleeding problems due to a platelet abnormality (platelet storage pool defect), and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin). more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The disease can cause poor functioning of the lungs, intestine, kidneys or heart. The major complication of the disease is pulmonary fibrosis and typically causes death in patients ages 40 - 50 years old. The disorder is common in Puerto Rico, where many of the clinical research studies on the disease have been conducted. Neither the full extent of the disease nor the basic cause of the disease is known. There is no known treatment for HPS.

HPS can be caused by mutations in several genes: HPS1, HPS3, HPS4, HPS5 and HPS6. HPS type 2, which includes immunodeficiency in its phenotype, is caused by mutation in the AP3B1 gene.

Read more at Wikipedia.org


[List your site here Free!]


Rapidly Progressive Hermansky-Pudlak Syndrome
From CHEST, 10/1/00 by Vilasinee Morkjaroenpong

Vilasinee Morkjaroenpong, MD, MPH, A. Polito, MD, S. Georas, MD, P. Terry, MD, MA--Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University Hospital, Baltimore, MD

Introduction: Hermansky Pudlak Syndrome (HPS) was first reported in 1959 by Hermansky and Pudlak. HPS consists of triad of oculocutaneous albinism, absence of platelet dense bodies, and lysosomal accumulation of ceroid lipofuscin. This rare autosomal recessive disease has also been associated with progressive interstitial lung disease. Majority of cases has been reported in patients with Puerto-Ricans ancestry with few reported cases in other ethnicity. This is a case report of rapidly progressive HPS in a pregnant African-American woman.

Case Presentation: A 32 years old African-American female presented to the Ob-gyn service at gestation age of 19 weeks with progressive shortness of breath which started 6 months prior to her visit. This progressive dyspnea on exertion has worsened for the past 2 weeks with accompanying nonproductive cough and no other systemic symptoms. She denied recent ill contacts or exposures to TB, and denied recent travel. Her medical history is significant for a diagnosis of oculocutaneous albinism, fixed gaze nystagmus, and strabismus since birth. She has had five full-term deliveries and three prior abortions without complications. She is an active intravenous drug abuser, and uses heroine, crack cocaine, with multiple unsuccessful attempts at detoxification and was incarcerated for 2 months for possession and skipping court. She is also an active cigarette smoker for half a pack a day for approximately 7 years. On admission, she is hypoxic on room air and afebrile. On examination, she was an albino with brown hair and patchy skin pigmentation. Fixed gazed nystagmus was notable on exams. Bilateral crackles and bilateral clubbing were also noted. Her cardiovascular exam was normal, and she has a gravid uterus, and the size was slightly smaller for her gestational age. Her arterial blood gas showed a pH of 7.42, pCO2 of 30, and PaO2 of 59 on room air. Her white blood cell counts were 6,800 with a normal differential, a hematocrit of 31, and a platelet count of 309,000. Her urine toxicology screen was positive for opiates. Her HIV test was negative as was her PPD test. Her chest x-ray revealed bilateral interstitial infiltrates, and her high resolution CT scan revealed extensive fibrosis and honeycombing with some areas of ground glass appearance (Figure 1 and 2). Based on this CT scan findings and physical exam, the differential diagnosis of usual interstitial pneumonitis, Lymphangioleiomyomatosis (LAM), and Hermansky-Pudlak Syndrome was entertained. Her respiratory status deteriorated despite intravenous empiric antibiotics and she underwent open lung biopsy, which showed extensive fibrosis and honeycombing. She remained, hypoxic requiring mechanical ventilation, with. high level of PEEP and FIO2. She died approximately a month after aggressive therapy with intravenous high doses of steroids and full mechanical ventilatory support. Given her albinism and extensive fibrosis found on lung biopsy (Figure 3), a diagnosis of Hermansky-Pudlak Syndrome was suspected. Blood sample was sent to Dr. James White's laboratory in University of Minnesota, who kindly perform the test and found that this patient's platelet has an absence of dense granules on electron microscopy, which is diagnostic of this disease. After the diagnosis was made, we have re-reviewed the pathology slides and Stand no evidence of ceroid deposition in the lung tissues. On further review of this patient's family tree, there was no linkage to any Puerto-Rican ancestry, but was significant for albinism in several of paternal cousins. Her mother and immediate siblings were not albinos.

Discussion: This patient presented in the terminal phase of interstitial lung disease, which appeared to have progressed rapidly. In Hermansky-Pudlak Syndrome, pulmonary disease begins with a restrictive component and progresses inexorably to death, usually in the fourth or fifth decade of life. It appears that this patient has a very rapid and fulminant course of the disease, but it maybe due to her substance abuse history and lack of medical care, that her pulmonary problems have not come to medical attention before. Pulmonary disease appears to be twice as common in women, occurring between the third and fourth decades. Most of the patients died of diffuse fibrotic lung disease, which resembles idiopathic pulmonary fibrosis. Currently, there is no effective therapy for this diffuse fibrotic process. The NIH is currently enrolling patients with Hermansky-Pudlak syndrome for antifibrotic drug therapy with perfenidone.

Conclusion: Oculoeutaneous albino patients who present with interstitial lung diseases should be tested for this rare disease. Diagnostic tests would include absence of dense granules on electron microscopy of platelets, or a documentation of ceroid lipofuscin deposition in pulmonary macrophages or other organs. This disease, although rare in non-Puerto Rican populations, can occur in almost any ethnicity.

COPYRIGHT 2000 American College of Chest Physicians
COPYRIGHT 2001 Gale Group

Return to Hermansky-Pudlak syndrome
Home Contact Resources Exchange Links ebay